prostaglandin-d2 has been researched along with ubenimex* in 3 studies
3 other study(ies) available for prostaglandin-d2 and ubenimex
Article | Year |
---|---|
Redifferentiation of cancer cells: bestatin, estradiol, and prostaglandin D2.
The induction of redifferentiation of cancer cells was studied. This was achievable with bestatin, especially in combination with sex hormones or prostaglandin D2, in murine undifferentiated mammary adenocarcinoma cells in vitro. Prostaglandin D2 also exerted a similar redifferentiating effect on M1 murine leukemia cells and a consecutive bestatin-hormone regimen was effective in endocrine tumors in man. Cancer redifferentiation may one day be developed into a clinical technique. Topics: Animals; Cell Cycle; Cell Differentiation; Cell Survival; Cells, Cultured; Contact Inhibition; DNA, Neoplasm; Estradiol; Leucine; Mammary Neoplasms, Experimental; Membranes; Mice; Microscopy, Electron, Scanning; Prostaglandin D2; Prostaglandins D | 1985 |
Principia of cancer therapy. X. Prostaglandin D2 triggers redifferentiation of the bestatin-treated breast cancer cells in vitro.
Topics: Adenocarcinoma; Animals; Cell Transformation, Neoplastic; Cells, Cultured; Female; Leucine; Mammary Neoplasms, Experimental; Mice; Prostaglandin D2; Prostaglandins D | 1985 |
Principia of cancer therapy. XI. Prostaglandin D2 induces redifferentiation of M1 leukemia cells in vitro irrespective of bestatin.
Topics: Animals; Cell Line; Cell Transformation, Neoplastic; Leucine; Leukemia, Myeloid, Acute; Mice; Prostaglandin D2; Prostaglandins D | 1985 |